Clinical Trials Directory

Trials / Sponsors / Fougera Pharmaceuticals Inc.

Fougera Pharmaceuticals Inc.

Industry · 12 registered clinical trials.

StatusTrialPhaseStarted
CompletedA Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in t
Acne Vulgaris
Phase 32016-09-21
CompletedA Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in
Plaque Psoriasis
Phase 32016-09-19
WithdrawnStudy to Determine the Pharmacokinetics of Product 0405
Atopic Dermatitis
Phase 32012-06-01
WithdrawnStudy Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pe
Atopic Dermatitis
Phase 32012-06-01
WithdrawnStudy Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pe
Atopic Dermatitis
Phase 32012-06-01
CompletedSafety Study Evaluating the Adrenal Suppression Potential of Product 0405 in Pediatric Subjects With Atopic De
Atopic Dermatitis
Phase 22010-11-01
WithdrawnTo Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque
Plaque Psoriasis
Phase 32010-09-01
CompletedStudy of 0416 Ointment in the Treatment of Atopic Dermatitis
Atopic Dermatitis
Phase 32008-01-01
CompletedStudy of 0444 Gel in the Treatment of Inflammatory Lesions of Rosacea
Inflammatory Rosacea
Phase 32008-01-01
CompletedStudy of 0417 Ointment in the Treatment of Atopic Dermatitis
Atopic Dermatitis
Phase 32008-01-01
CompletedCutivate Lotion HPA Axis Pediatric Study
Atopic Dermatitis
Phase 42007-07-01
CompletedStudy to Evaluate Effect of Pandel Cream 0.1% on HPA Axis in Pediatric and Adult Population
Psoriasis, Atopic Dermatitis
Phase 42004-06-01